Two phase 3 RCTs (748 patients after cataract surgery): clobetasol propionate 0.05% vs placebo eye drops gave anterior chamber cell clearance at day 15 in 58.2% vs 17.3% and no pain in 88.5% vs 45.8%; safety was similar to placebo.
RCTn = 748
Korenfeld et al. Clobetasol Propionate Ophthalmic Suspension to Treat Ocular Inflammation and Pain after Uncomplicated Cataract Surgery